ADMA Biologics ADMA EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
Based on trailing twelve months.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's EBITDA margin?
- ADMA Biologics (ADMA) reported EBITDA margin of 43.7% in Q1 2026.
- How has ADMA Biologics's EBITDA margin changed year-over-year?
- ADMA Biologics's EBITDA margin increased by 25.6% year-over-year, from 34.8% to 43.7%.
- What is the long-term trend for ADMA Biologics's EBITDA margin?
- Over 5 years (2020 to 2025), ADMA Biologics's EBITDA margin has grown at a -23.0% compound annual growth rate (CAGR), from -144.4% to 39.1%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.